Private Wealth

Why GLP-1 weight loss drugs are catching investor attention

Person image

Welcome to the latest edition of our SB Talks podcast, where we explore the important elements of your financial world – from investments to strategy, from retirement planning to intergenerational wealth.

In this episode of SB Talks, CEO Vincent O’Neill is joined by Chief Investment Officer, Nick Ryder.

 

They discuss:

  • The RBA’s widely anticipated rate hike and where to from here?
  • Driving factors behind Australia’s higher-than-expected inflation numbers
  • Whether geopolitical risks impact portfolio positioning?
  • The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL

 

Click here to listen!

Click here to watch!

Meet Nick Ryder

Nick draws on an expansive career built over 30+ years in the investment management and financial services industries. With him, he brings significant and hands-on experience across asset classes, including domestic and global equities, fixed income and Nick’s particular expertise in alternatives and private assets. We look forward to formally introducing Nick to you.

Read More
Meet Nick Ryder
https://stanfordbrown.com.au/wp-content/uploads/2020/10/STB_Website_News_Media-Enquiries.jpg

How Much Do I Need… and Will I Have Enough?

Read more
https://stanfordbrown.com.au/wp-content/uploads/2020/10/STB_Website_Private-Wealth_Advise-For_Retirees-1.jpg

Ten Golden Rules of Retiring Retirement

Read more
https://stanfordbrown.com.au/wp-content/uploads/2020/10/STB_Website_Private-Wealth_Wealth-Transfer_Intergenerational-Planning.jpg

How to divide wealth without dividing your blended family

Read more